✦ LIBER ✦

Functional factor VIII made with von Willebrand factor at high levels in transgenic milk

✍ Scribed by S. W. PIPE; H. MIAO; S. P. BUTLER; J. CALCATERRA; W. H. VELANDER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune tolerance therapy utilizing facto

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Experience with Optivate®, a new high pu

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Immune tolerance induction with high von

✍ H. PLATOKOUKI; H. PERGANTOU; P. XAFAKI; A. KOMITOPOULOU; S. ARONIS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

Clinical experience with Optivate®, high

✍ M. MATYSIAK; H. BOBROWSKA; W. BALWIERZ; A. CHYBICKA; J. R. KOWALCZYK; R. SHAIKH- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Relationship between ABO and Secretor ge

✍ Michael Schleef; Erwin Strobel; Andrea Dick; Josef Frank; Wolfgang Schramm; Mich 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB